Interpace Diag Group (IDXG) Stock Price & Overview

NASDAQ:IDXG

Current stock price

3.92
+0.02 (+0.51%)
At close:
3.76
-0.16 (-4.08%)
After Hours:

The current stock price of IDXG is 3.92 null. Today IDXG is up by 0.51%. In the past month the price decreased by -11.51%. In the past year, price decreased by -52.31%.

IDXG Key Statistics

52-Week Range2.5721 - 9.12
Current IDXG stock price positioned within its 52-week range.
1-Month Range3.72 - 5.9899
Current IDXG stock price positioned within its 1-month range.
Market Cap
16.088M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-4.94
Dividend Yield
N/A

IDXG Stock Performance

Today
+0.51%
1 Week
-11.71%
1 Month
-11.51%
3 Months
+18.29%
Longer-term
6 Months +9.19%
1 Year -52.31%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

IDXG Stock Chart

Interpace Diag Group / IDXG Daily stock chart

IDXG Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to IDXG. When comparing the yearly performance of all stocks, IDXG is a bad performer in the overall market: 95.5% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IDXG Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IDXG. IDXG may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IDXG Earnings

Next Earnings DateMay 9, 2022
Last Earnings DateMar 29, 2022

IDXG Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y-33000%
Revenue Next YearN/A

IDXG Financial Highlights

Over the last trailing twelve months IDXG reported a non-GAAP Earnings per Share(EPS) of -4.9399999999999995. The EPS decreased by -25.06% compared to the year before.


Income Statements
Revenue(TTM)26.97M
Net Income(TTM)-28.80M
Industry RankSector Rank
PM (TTM) -106.8%
ROA -56.81%
ROE N/A
Debt/Equity -0.16
Chartmill High Growth Momentum
EPS Q2Q%99.41%
Sales Q2Q%6.77%
EPS 1Y (TTM)-25.06%
Revenue 1Y (TTM)4.37%

IDXG Ownership

Ownership
Inst Owners6.67%
Shares4.10M
FloatN/A
Ins Owners25.2%
Short Float %0.16%
Short Ratio0.03

About IDXG

Company Profile

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.

Company Info

Interpace Diag Group

MORRIS CORPORATE CENTER 1 BUILDING C 300 INTERPACE PARKWAY

PARSIPPANY NJ 07054

CEO: Jack E. Stover

Phone: 855-776-6419

Interpace Diag Group / IDXG FAQ

Can you describe the business of Interpace Diag Group?

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.


What is the current price of IDXG stock?

The current stock price of IDXG is 3.92 null. The price increased by 0.51% in the last trading session.


Does Interpace Diag Group pay dividends?

IDXG does not pay a dividend.


What is the ChartMill technical and fundamental rating of IDXG stock?

IDXG has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is Interpace Diag Group (IDXG) stock traded?

IDXG stock is listed on the Nasdaq exchange.